Tackling Multiple-Drug-Resistant Bacteria With Conventional and Complex Phytochemicals

Area of Science:

• Microbiology
• Pharmacology
• Natural Product Chemistry

Background:

• Antibiotic resistance is a growing global health crisis, driven by bacterial adaptation and the overuse of existing antimicrobial drugs.
• Multidrug-resistant (MDR) bacterial strains complicate treatment, increase healthcare costs, and pose significant challenges in managing chronic illnesses.
• The rapid evolution of bacteria and the emergence of resistance necessitate the exploration of alternative therapeutic strategies.

Purpose of the Study:

• To review the mechanisms of antibiotic resistance in bacteria.
• To explore the potential of phytochemicals as an alternative or complementary approach to antibiotics.
• To highlight the scientific evidence supporting the efficacy of phytochemicals against MDR pathogens.

Main Methods:

• Review of existing literature on bacterial antibiotic resistance mechanisms.
• Analysis of studies investigating the inhibitory effects of various phytochemical classes (alkaloids, phenols, coumarins, terpenes) against MDR pathogens.
• Examination of research on phytochemicals targeting bacterial membrane proteins, efflux pumps, biofilms, and quorum sensing.

Main Results:

• Phytochemicals demonstrate significant inhibitory potential against MDR bacteria through diverse mechanisms.
• Plant-derived compounds can counteract key factors promoting antibiotic resistance, including biofilms and cell-to-cell communication.
• The complex composition of plant extracts makes bacterial resistance development more challenging.

Conclusions:

• Phytochemicals represent a viable strategy to combat antibiotic resistance and complement existing therapies.
• Further research into the molecular, biochemical, and clinical aspects of phytochemicals is warranted for human therapeutic applications.
• Investigations into clinical efficacy, safety, toxicity, and affordability are crucial for the successful integration of phytochemicals into treatment regimens.